A limitation to efficient lentivirus-mediated airway gene transfer is the lack of receptors to commonly used viral envelopes on the luminal surface of airway epithelia. The use of viral envelopes with natural tropism to the airway could be useful for overcoming this limitation
Background Attempts at gene therapy for the pulmonary manifestations of Cystic Fibrosis have relied ...
Over the last two decades, enormous effort has been focused on developing virus-based gene delivery ...
We have characterized the ability of adeno-associated virus (AAV) serotypes 1–9 in addition to ninet...
A limitation to efficient lentivirus-mediated airway gene transfer is the lack of receptors to commo...
Recombinant lentiviral vectors (LV) are an attractive vehicle for gene delivery to the lung due to t...
Published in Journal of Gene Medicine, 2007; 9 (5):362-368 at www.interscience.wiley.comLentivirus v...
Gene therapy of cystic fibrosis (CF) lung disease needs highly efficient delivery and long-lasting c...
RATIONALE: Ongoing efforts to improve pulmonary gene transfer thereby enabling gene therapy for the ...
Extent: 11p.Background Poor gene transfer efficiency has been a major problem in developing an effec...
BackgroundPersistent airway gene expression can be achieved in mouse nasal airway using a vesicular ...
Persistent viral vector-mediated transgene expression in the airways requires delivery to cells with...
Cystic fibrosis (CF) lung disease is an ideal candidate for a genetic therapy. It has been shown pre...
A gene therapy for cystic fibrosis (CF) lung disease by intralumenal delivery of therapeutic transge...
Copyright © 2010 John Wiley & Sons, Ltd.BackgroundCystic fibrosis (CF) is caused by a defect in cyst...
The potential for gene therapy to be an effective treatment for cystic fibrosis (CF) airway disease ...
Background Attempts at gene therapy for the pulmonary manifestations of Cystic Fibrosis have relied ...
Over the last two decades, enormous effort has been focused on developing virus-based gene delivery ...
We have characterized the ability of adeno-associated virus (AAV) serotypes 1–9 in addition to ninet...
A limitation to efficient lentivirus-mediated airway gene transfer is the lack of receptors to commo...
Recombinant lentiviral vectors (LV) are an attractive vehicle for gene delivery to the lung due to t...
Published in Journal of Gene Medicine, 2007; 9 (5):362-368 at www.interscience.wiley.comLentivirus v...
Gene therapy of cystic fibrosis (CF) lung disease needs highly efficient delivery and long-lasting c...
RATIONALE: Ongoing efforts to improve pulmonary gene transfer thereby enabling gene therapy for the ...
Extent: 11p.Background Poor gene transfer efficiency has been a major problem in developing an effec...
BackgroundPersistent airway gene expression can be achieved in mouse nasal airway using a vesicular ...
Persistent viral vector-mediated transgene expression in the airways requires delivery to cells with...
Cystic fibrosis (CF) lung disease is an ideal candidate for a genetic therapy. It has been shown pre...
A gene therapy for cystic fibrosis (CF) lung disease by intralumenal delivery of therapeutic transge...
Copyright © 2010 John Wiley & Sons, Ltd.BackgroundCystic fibrosis (CF) is caused by a defect in cyst...
The potential for gene therapy to be an effective treatment for cystic fibrosis (CF) airway disease ...
Background Attempts at gene therapy for the pulmonary manifestations of Cystic Fibrosis have relied ...
Over the last two decades, enormous effort has been focused on developing virus-based gene delivery ...
We have characterized the ability of adeno-associated virus (AAV) serotypes 1–9 in addition to ninet...